DK121316B - Fremgangsmåde til afsvækkelse af levende mæslingevirus. - Google Patents

Fremgangsmåde til afsvækkelse af levende mæslingevirus.

Info

Publication number
DK121316B
DK121316B DK480262AA DK480262A DK121316B DK 121316 B DK121316 B DK 121316B DK 480262A A DK480262A A DK 480262AA DK 480262 A DK480262 A DK 480262A DK 121316 B DK121316 B DK 121316B
Authority
DK
Denmark
Prior art keywords
measles virus
live measles
attenuating
attenuating live
virus
Prior art date
Application number
DK480262AA
Other languages
English (en)
Inventor
A Schwarz
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Publication of DK121316B publication Critical patent/DK121316B/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/165—Mumps or measles virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK480262AA 1961-11-08 1962-11-07 Fremgangsmåde til afsvækkelse af levende mæslingevirus. DK121316B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US150896A US3133861A (en) 1961-11-08 1961-11-08 Attenuated live measles virus vaccine and method of production

Publications (1)

Publication Number Publication Date
DK121316B true DK121316B (da) 1971-10-04

Family

ID=22536464

Family Applications (1)

Application Number Title Priority Date Filing Date
DK480262AA DK121316B (da) 1961-11-08 1962-11-07 Fremgangsmåde til afsvækkelse af levende mæslingevirus.

Country Status (9)

Country Link
US (1) US3133861A (da)
BR (1) BR6244423D0 (da)
CA (1) CA933863A (da)
CH (1) CH429024A (da)
DK (1) DK121316B (da)
FR (1) FR3857M (da)
GB (1) GB1000907A (da)
LU (1) LU42653A1 (da)
SE (1) SE369732B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB960850A (en) * 1961-09-08 1964-06-17 Wellcome Found Measles virus vaccine
US3468758A (en) * 1965-08-17 1969-09-23 American Cyanamid Co Measles vaccine attenuated through avian chorio-allantoic membrane
FR2076787A5 (en) * 1970-01-28 1971-10-15 Merieux Inst Lyophilisation stabiliser - for viruses contg potassium phosphate lactose and albumin
US4147772A (en) * 1976-02-03 1979-04-03 Merck & Co., Inc. Vaccine stabilizer
US4211843A (en) * 1977-11-30 1980-07-08 L'institut Armand-Frappier Strain of measles virus and process of producing the same
US4273762A (en) * 1979-12-03 1981-06-16 Merck & Co., Inc. Lyophilization process for live viral compositions
US4338335A (en) * 1980-02-05 1982-07-06 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
US4303645A (en) * 1980-04-18 1981-12-01 Cornell Research Foundation, Inc. Modified living canine parvovirus vaccine
FR2532548B1 (fr) * 1982-09-03 1985-11-08 Pasteur Institut Nouveau procede de production de vaccins presentant un titre eleve de virus et vaccins tres purifies, a titre eleve de virus, ainsi obtenus
US7118740B1 (en) * 2000-09-22 2006-10-10 Mayo Foundation For Medical Education And Research Method for limiting the growth of cancer cells using an attenuated measles virus
GB2477100B (en) 2010-01-20 2016-02-03 Unwin C N Ltd Anchorage systems and devices

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990335A (en) * 1955-05-06 1961-06-27 Wilton R Earle Fluid suspension culture method for fixed tissue cells
US2912361A (en) * 1956-11-28 1959-11-10 Sterling Drug Inc Canine distemper vaccine and its preparation

Also Published As

Publication number Publication date
GB1000907A (en) 1965-08-11
CH429024A (de) 1967-01-31
CA933863A (en) 1973-09-18
LU42653A1 (da) 1963-05-08
US3133861A (en) 1964-05-19
BR6244423D0 (pt) 1973-05-24
FR3857M (da) 1966-01-24
SE369732B (da) 1974-09-16

Similar Documents

Publication Publication Date Title
DK104168C (da) Fremgangsmåde til fremstilling af mono-biguanider.
DK103796C (da) Fremgangsmåde til fremstilling af et enterisk præparat.
DK121316B (da) Fremgangsmåde til afsvækkelse af levende mæslingevirus.
DK108985C (da) Fremgangsmåde til fremstilling af mæslingevaccine indeholdende levende, svækket mæslingevirus.
DK106988C (da) Fremgangsmåde til imprægnering af træ.
DK105143C (da) Fremgangsmåde til tørring af tobak.
DK110104C (da) Fremgangsmåde til samling af rørstykker.
DK104193C (da) Fremgangsmåde til stabilisering af labile, antigene virusmaterialer.
DK107027C (da) Fremgangsmåde til fremstilling af 3-hydroxy-benzisoxazoler.
DK106240C (da) Fremgangsmåde til fremstilling af et jern-pectin-kompleks.
DK108455C (da) Fremgangsmåde til fremstilling af i 5-stillingen usubstituerede 2-amino-benzophenoner.
DK108227C (da) Fremgangsmåde til fremstilling af 3-carbonhydridoxy-17α-halogenethinyl-19-nor-3,5-androstadien-17β-oler.
DK122824B (da) Fremgangsmåde til afsvækkelse af virus.
DK106184C (da) Fremgangsmåde til fremstilling af alkylaralkylftalater.
DK103021C (da) Fremgangsmåde til rensning af ɛ-caprolactam.
DK102929C (da) Fremgangsmåde til sterilisering af vandige kompositioner.
DK106189C (da) Fremgangsmåde til fremstilling af punktelektroder.
DK104136C (da) Fremgangsmåde til fremstilling af benzensulfonylsemicarbazider.
DK104055C (da) Fremgangsmåde til fremstilling af 6-methoxytetraloner.
DK97204C (da) Fremgangsmåde til præservering af poliomyelitis-vaccine.
DK109196C (da) Fremgangsmåde til fremstilling af gentiobiose.
DK100195C (da) Fremgangsmåde til konservering af træ.
DK105080C (da) Fremgangsmåde til åbning af dybfrosne skaldyr.
DK97871C (da) Fremgangsmåde til forbedring af kvaliteten af humle.
DK101879C (da) Apparat til behandling af overflader.